Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature

Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration‐resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yausep, Oliver E., Agarwal, Raksheeth, Aulina, Rifqha, Wijaya, Anthony E., Amaia, Ilonka, Moekti, Addina W., Rinaldi, Ikhwan, Hamid, Agus Rizal A. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692971/
https://www.ncbi.nlm.nih.gov/pubmed/31428397
http://dx.doi.org/10.1002/ccr3.2288
_version_ 1783443626092658688
author Yausep, Oliver E.
Agarwal, Raksheeth
Aulina, Rifqha
Wijaya, Anthony E.
Amaia, Ilonka
Moekti, Addina W.
Rinaldi, Ikhwan
Hamid, Agus Rizal A. H.
author_facet Yausep, Oliver E.
Agarwal, Raksheeth
Aulina, Rifqha
Wijaya, Anthony E.
Amaia, Ilonka
Moekti, Addina W.
Rinaldi, Ikhwan
Hamid, Agus Rizal A. H.
author_sort Yausep, Oliver E.
collection PubMed
description Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration‐resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.
format Online
Article
Text
id pubmed-6692971
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66929712019-08-19 Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature Yausep, Oliver E. Agarwal, Raksheeth Aulina, Rifqha Wijaya, Anthony E. Amaia, Ilonka Moekti, Addina W. Rinaldi, Ikhwan Hamid, Agus Rizal A. H. Clin Case Rep Case Reports Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration‐resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point. John Wiley and Sons Inc. 2019-07-11 /pmc/articles/PMC6692971/ /pubmed/31428397 http://dx.doi.org/10.1002/ccr3.2288 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yausep, Oliver E.
Agarwal, Raksheeth
Aulina, Rifqha
Wijaya, Anthony E.
Amaia, Ilonka
Moekti, Addina W.
Rinaldi, Ikhwan
Hamid, Agus Rizal A. H.
Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title_full Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title_fullStr Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title_full_unstemmed Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title_short Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature
title_sort prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: an evidence‐based case report and review of literature
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692971/
https://www.ncbi.nlm.nih.gov/pubmed/31428397
http://dx.doi.org/10.1002/ccr3.2288
work_keys_str_mv AT yausepolivere prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT agarwalraksheeth prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT aulinarifqha prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT wijayaanthonye prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT amaiailonka prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT moektiaddinaw prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT rinaldiikhwan prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature
AT hamidagusrizalah prognosticvalueofplatelettolymphocyteratioinpredictingsurvivalofpatientswithmetastaticcastrationresistantprostatecancerreceivingabirateroneacetateanevidencebasedcasereportandreviewofliterature

Ejemplares similares